Article Cited by others


Peripheral monocyte count: an independent diagnostic and prognostic biomarker for prostate cancer - a large Chinese cohort study

Wang Yan-Qing, Zhu Yin-Jie, Pan Jia-Hua, Xu Fan, Shao Xiao-Guang, Sha Jian-Jun, Liu Qiang, Huang Yi-Ran, Dong Bai-Jun, Xue Wei

Year : 2017| Volume: 19| Issue : 5 | Page no: 579-585

   This article has been cited by
1 Main Inflammatory Cells and Potentials of Anti-Inflammatory Agents in Prostate Cancer
Takuji Hayashi,Kazutoshi Fujita,Makoto Matsushita,Norio Nonomura
Cancers. 2019; 11(8): 1153
[Pubmed]  [Google Scholar] [DOI]
2 Postoperative Monocyte Count Change Is a Better Predictor of Survival Than Preoperative Monocyte Count in Esophageal Squamous Cell Carcinoma
Qian Song,Jun-zhou Wu,Sheng Wang
BioMed Research International. 2019; 2019: 1
[Pubmed]  [Google Scholar] [DOI]
3 Prognostic significance of elevated pretreatment systemic inflammatory markers for patients with prostate cancer: a meta-analysis
Hao Peng,Xiaogang Luo
Cancer Cell International. 2019; 19(1)
[Pubmed]  [Google Scholar] [DOI]
4 Androgen deprivation therapy promotes an obesity-like microenvironment in periprostatic fat
Stefano Mangiola,Ryan Stuchbery,Patrick McCoy,Ken Chow,Natalie Kurganovs,Michael Kerger,Anthony Papenfuss,Christopher M Hovens,Niall M Corcoran
Endocrine Connections. 2019; 8(5): 547
[Pubmed]  [Google Scholar] [DOI]
5 Preoperative lymphocyte-to-monocyte ratio (LMR) could independently predict overall survival of resectable gastric cancer patients
Yu-Chen Pan,Zhi-Fang Jia,Dong-Hui Cao,Yan-Hua Wu,Jing Jiang,Si-Min Wen,Dan Zhao,Song-Ling Zhang,Xue-Yuan Cao
Medicine. 2018; 97(52): e13896
[Pubmed]  [Google Scholar] [DOI]


Read this article